Source link : https://las-vegas-news.com/medicares-50-copay-pilot-brings-glp-1-weight-loss-drugs-within-reach-for-many-seniors/
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know – Image for illustrative purposes only (Image credits: Unsplash)
Medicare beneficiaries facing obesity could soon fill prescriptions for popular GLP-1 drugs like Wegovy and Zepbound at just $50 a month. The Centers for Medicare & Medicaid Services announced a pilot program that marks a significant departure from longstanding restrictions on covering weight loss treatments. Set to launch on July 1, 2026, this initiative aims to address affordability barriers for medications that have transformed weight management but remained out of reach for many without insurance support.
A Pilot Program Reshaping Access to Obesity Treatments
The Medicare GLP-1 Bridge program represents a temporary but targeted expansion of coverage. It will operate from July 1, 2026, through December 31, 2027, serving as a stopgap before any potential permanent changes in 2028. CMS designed it to cover specific GLP-1 formulations approved for weight loss, including injectable and pill versions of Wegovy, the KwikPen version of Zepbound, and the Foundayo pill.
Unlike standard Medicare benefits, this pilot routes prescriptions through a centralized prior authorization system managed by contractor Humana. Physicians submit requests regardless of their Medicare provider status, and approved patients pick up medications at pharmacies with the fixed $50 copayment. The structure bypasses traditional Part D plans, creating a…
—-
Author : Matthias Binder
Publish date : 2026-05-06 17:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8